STOCK TITAN

JPMorgan discloses passive 4.0% BMY stake; sole vote 71.7M

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Bristol-Myers Squibb (BMY): Ownership update. JPMorgan Chase & Co. filed an amended Schedule 13G reporting beneficial ownership of 81,890,781 shares, representing 4.0% of BMY’s common stock as of 09/30/2025.

The filing lists 71,741,508 shares with sole voting power and 790,804 with shared voting power. It also reports 81,264,020 shares with sole dispositive power and 625,305 with shared dispositive power. JPMorgan certified the securities were acquired and are held in the ordinary course of business and not to change or influence control.

Positive

  • None.

Negative

  • None.

Insights

Passive 13G/A shows JPMorgan at 4.0% of BMY.

JPMorgan reports a 4.0% beneficial stake in BMY (81,890,781 shares) as of 09/30/2025, filed on a Schedule 13G/A, the passive ownership form. The firm details sole vs. shared voting and dispositive powers, indicating typical institutional custody and advisory roles.

The certification states the position is held in the ordinary course and not for influencing control, aligning with 13G eligibility. The stake is below the 5% threshold referenced in the form, a level often associated with fewer heightened reporting triggers.

Actual market impact depends on portfolio and client decisions. Subsequent filings may update ownership levels if they change materially under applicable rules.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



JPMORGAN CHASE & CO.
Signature:Rachel Tsvaygoft
Name/Title:Vice President
Date:10/31/2025

FAQ

What did JPMorgan disclose about BMY (Bristol-Myers Squibb) in this 13G/A?

JPMorgan reported beneficial ownership of 81,890,781 BMY shares, equal to 4.0% of the class as of 09/30/2025.

How much voting power did JPMorgan report over BMY shares?

They listed 71,741,508 shares with sole voting power and 790,804 with shared voting power.

What dispositive power did JPMorgan report over its BMY holdings?

They reported 81,264,020 shares with sole dispositive power and 625,305 with shared dispositive power.

Is JPMorgan’s BMY position passive or for influencing control?

The certification states the position was acquired and is held in the ordinary course and not to change or influence control.

What is the event date referenced in the BMY 13G/A?

The date of the event requiring the filing is 09/30/2025.

Who signed the 13G/A filing and when?

It was signed by Rachel Tsvaygoft, Vice President, dated 10/31/2025.
Bristol-Myers Squibb Co

NYSE:BMY

BMY Rankings

BMY Latest News

BMY Latest SEC Filings

BMY Stock Data

110.50B
2.03B
0.07%
82.82%
1.53%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
PRINCETON